CRISPR/Cas9 technology generated a G to A change at position 874 (c.874G>A) resulting in a glycine to arginine substitution at amino acid 292 (p.G292R) in exon 6. Three silent nucleotide mutations were also generated to prevent Cas9 editing. This variant is associated with poor performance in cochlear implant recipients with hearing loss. (J:332624)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count